- Home
- EPIX vs LICN Comparison
EPIX vs LICN Comparison
Compare EPIX & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPIX
- LICN
- Stock Information
- Founded
- EPIX 2009
- LICN 2004
- Country
- EPIX Canada
- LICN China
- Employees
- EPIX N/A
- LICN N/A
- Industry
- EPIX Biotechnology: Pharmaceutical Preparations
- LICN
- Sector
- EPIX Health Care
- LICN
- Exchange
- EPIX Nasdaq
- LICN Nasdaq
- Market Cap
- EPIX 77.2M
- LICN 83.8M
- IPO Year
- EPIX N/A
- LICN 2023
- Fundamental
- Price
- EPIX $1.75
- LICN $0.15
- Analyst Decision
- EPIX Hold
- LICN
- Analyst Count
- EPIX 3
- LICN 0
- Target Price
- EPIX $2.00
- LICN N/A
- AVG Volume (30 Days)
- EPIX 425.3K
- LICN 20.0M
- Earning Date
- EPIX 02-11-2025
- LICN 12-31-2024
- Dividend Yield
- EPIX N/A
- LICN N/A
- EPS Growth
- EPIX N/A
- LICN 36.90
- EPS
- EPIX N/A
- LICN 0.28
- Revenue
- EPIX N/A
- LICN $41,929,000.00
- Revenue This Year
- EPIX N/A
- LICN N/A
- Revenue Next Year
- EPIX N/A
- LICN N/A
- P/E Ratio
- EPIX N/A
- LICN $0.55
- Revenue Growth
- EPIX N/A
- LICN 24.86
- 52 Week Low
- EPIX $1.40
- LICN $0.13
- 52 Week High
- EPIX $11.67
- LICN $2.44
- Technical
- Relative Strength Index (RSI)
- EPIX 41.97
- LICN 24.70
- Support Level
- EPIX $1.70
- LICN $0.13
- Resistance Level
- EPIX $1.85
- LICN $0.17
- Average True Range (ATR)
- EPIX 0.10
- LICN 0.02
- MACD
- EPIX 0.03
- LICN 0.06
- Stochastic Oscillator
- EPIX 43.66
- LICN 16.61
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.
About LICN Lichen China Limited
Lichen China Ltd is a holding company. The company, along with its subsidiaries provides financial and taxation solution services; education support services; and software and maintenance services. The company generates Majority revenue from Financial and taxation solution services.